Literature DB >> 19343045

Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation.

Yiqing Yang1, Jun Li, Xiaoping Lin, Yanzong Yang, Kui Hong, Lei Wang, Jinqiu Liu, Li Li, Dinghong Yan, Dandan Liang, Junjie Xiao, Hongmei Jin, Jie Wu, Yangyang Zhang, Yi-Han Chen.   

Abstract

Accumulating evidence reveals that genetic variants play pivotal roles in familial atrial fibrillation (AF). However, the molecular defects in most patients with AF remain to be identified. Here, we report on three novel KCNA5 mutations that were identified in 4 of 120 unrelated AF families. Among them, T527M was found in two AF families, and A576V and E610K in two other AF families, respectively. The mutations T527M and A576V were also detected in 2 and 1 of 256 patients with idiopathic AF, respectively. The same mutations were not observed in 200 secondary AF patients and 500 controls. Functional analyses revealed consistent loss-of-function effects of mutant KCNA5 proteins on the ultrarapidly activating delayed rectifier potassium currents. These findings expand the spectrum of mutations in KCNA5 linked to AF and provide new insight into the molecular mechanism involved in AF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343045     DOI: 10.1038/jhg.2009.26

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  45 in total

1.  KCNA5 gene polymorphism associate with idiopathic atrial fibrillation.

Authors:  Li Tian; Gang Liu; Le Wang; Mingqi Zheng; Yongjun Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 3.  Novel pharmacological targets for the rhythm control management of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2011-08-17       Impact factor: 12.310

Review 4.  Ion Channels in the Heart.

Authors:  Daniel C Bartos; Eleonora Grandi; Crystal M Ripplinger
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

Review 5.  Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.

Authors:  William T Harkcom; Geoffrey W Abbott
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

Review 6.  The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Authors:  Dawood Darbar
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

7.  Atrial Fibrillation and SCN5A Variants.

Authors:  Eleonora Savio-Galimberti; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

Review 8.  A contemporary review on the genetic basis of atrial fibrillation.

Authors:  Jason D Roberts; Michael H Gollob
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

Review 9.  Coronary microvascular Kv1 channels as regulatory sensors of intracellular pyridine nucleotide redox potential.

Authors:  Marc M Dwenger; Vahagn Ohanyan; Manuel F Navedo; Matthew A Nystoriak
Journal:  Microcirculation       Date:  2018-01       Impact factor: 2.628

10.  Atrial fibrillation in cardiac channelopathies.

Authors:  Jayachandran Thejus; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2009-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.